Keith Powell

About

Keith Powell has been Chairman of Domainex since 2007, having previously been the company's Chief Executive Officer. He is also the Chief Executive Officer of the biotech company, PolyTherics. Keith has extensive experience in the management of large and small biotech companies, particularly in area of fund-raising: in 2007 PolyTherics secured £2.3M from a portfolio of investors, and he successfully led SPEAR into an $8.5M series B financing round. Keith was formerly Senior Vice President of Maxygen, a protein modification company, where he was responsible for the execution of research partnerships that generated more than $20M of revenue before taking into account milestone and royalty payments. Prior to joining Maxygen, Keith was Head of Intellectual Property and Head of Discovery at Zeneca.

Investment Focus